Results for this period
First quarter1 June 2026 to 31 August 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
F&I services and HR&OS services remained solid, and high-gross-profit-margin consulting revenue in C&Br services increased. However, net sales declined due to the反動 from sales of large medical equipment and other products recorded in the same period of the previous year.
None ("There are no applicable matters.")
| Item | Details |
|---|---|
| Fiscal Period Classification | First quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 June 2026 to 31 August 2026 |
| Net Sales | ¥428 million (YoY -1.7%) |
| Operating profit | ¥106 million (YoY +100.7%) |
| Ordinary income | ¥106 million (YoY +30.6%) |
| Profit attributable to owners of the parent | ¥75 million (YoY +33.4%) |
| Net income per share | ¥32.57 |
| Equity ratio | End of the current fiscal period 20.2 / End of previous period 22.1 |
| Total assets | ¥11,757 million |
| Net assets | ¥2,379 million |
| Full-year earnings forecast | Net Sales ¥2,023 million (YoY +24.6%) / Operating profit ¥362 million (YoY +32.9%) / Ordinary income ¥362 million (YoY +16.5%) / Net income ¥247 million (YoY +11.3%) |
| Revision to Earnings Forecast | No revision |
| Annual Dividend Forecast | ¥20 → ¥20（0.0%） |
| Depreciation and amortization | ¥3,205 thousand |
| Disclosure regarding the going concern assumption | None ("There are no applicable matters.") |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | None (no additions or exclusions) |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | None (対象者：Not disclosed) |
| Issued Shares at Period-End | 2,317,000 shares |
| Treasury Shares at Period-End | — shares |
| Factors Behind Changes in Business Performance | F&I services and HR&OS services remained solid, and high-gross-profit-margin consulting revenue in C&Br services increased. However, net sales declined due to the反動 from sales of large medical equipment and other products recorded in the same period of the previous year. |
Items this document does not state (14)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.F&I services and HR&OS services remained solid, and consulting revenue in C&Br services, which has a high gross profit margin, increased. However, net sales declined due to the反動 from sales of large medical equipment and other products in the same period of the previous year. The increase in operating profit was primarily attributable to growth in consulting revenue in C&Br services.